Pancreatic adenocarcinoma is often associated with severe, difficult-to-manage pain that significantly impacts quality of life. Autonomix Medical’s proprietary technology aims to target and modulate ... Please provide your email address to receive an email when new articles are posted on .
Chronic HCV infection was associated with a 1.8-fold increased risk for pancreatic ductal adenocarcinoma. Markets Insider: Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026 Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026 Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off immunotherapy, and how to flip that script so the same tumors start ... ascopubs.org: Phase II Study of Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and Fluorouracil in Locally Advanced Pancreatic Carcinoma: BTCRC-GI15-067 Liposomal formulation of irinotecan-based combination chemotherapy is a standard regimen for palliative treatment of patients with metastatic pancreatic carcinoma (PC). We investigated the efficacy, ...
pancreatic adenocarcinoma, Phase II Study of Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and Fluorouracil in Locally Advanced Pancreatic Carcinoma: BTCRC-GI15-067
